Inoue, Satoshi

Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression

Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell

Redox biology and oxidative stressGlutathione Transferases and Polymorphisms

Cited by 993

Silk fibroin of Bombyx mori is secreted, assembling a high molecular mass elementary unit consisting of H-chain, L-chain, and P25, with a 6:6:1 molar ratio

Inoue, S., Tanaka, K., Arisaka, F., Kimura, S., Ohtomo, K., & Mizuno, S. (2000) · Journal of Biological Chemistry

Silk-based biomaterials and applicationsSilkworms and Sericulture Research

Cited by 784

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Sasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes & Development

Cancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment

Cited by 296

BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival

Gorrini, C., Baniasadi, P. S., Harris, I. S., Silvester, J., Inoue, S., Snow, B., Joshi, P. A., Wakeham, A., Molyneux, S. D., Martin, B., et al. (2013) · Journal of Experimental Medicine

Genomics, phytochemicals, and oxidative stressBRCA gene mutations in cancer

Cited by 289

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

Yamada, Y., Katagiri, H., Hamamoto, Y., Deenadayalan, S., Navarria, A., Nishijima, K., Seino, Y., Fukushima, Y., Hamamoto, Y., Hisatomi, A., et al. (2020) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 228

A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle

Ikeda, K., Shiba, S., Horie-Inoue, K., Shimokata, K., & Inoue, S. (2013) · Nature Communications

Mitochondrial Function and PathologyCoenzyme Q10 studies and effects

Cited by 152

Mutant IDH is sufficient to initiate enchondromatosis in mice

Hirata, M., Sasaki, M., Cairns, R. A., Inoue, S., Puviindran, V., Li, W. Y., Snow, B. E., Jones, L. D., Wei, Q., Sato, S., et al. (2015) · Proceedings of the National Academy of Sciences

Bone Tumor Diagnosis and TreatmentsOsteoarthritis Treatment and Mechanisms

Cited by 115

Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer

Takayama, K.-I., Suzuki, T., Fujimura, T., Takahashi, S., & Inoue, S. (2018) · Molecular Cancer Research

Ubiquitin and proteasome pathwaysProstate Cancer Treatment and Research

Cited by 104

Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases

Sato, K., Takayama, K.-I., & Inoue, S. (2023) · Frontiers in Aging Neuroscience

RNA Interference and Gene DeliveryNeuroinflammation and Neurodegeneration Mechanisms

Cited by 41

Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer

Fujimura, T., Takahashi, S., Urano, T., Kumagai, J., Murata, T., Takayama, K., Ogushi, T., Horie-Inoue, K., Ouchi, Y., Kitamura, T., et al. (2009) · Urology

Prostate Cancer Treatment and ResearchPharmacogenetics and Drug Metabolism

Cited by 34

Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients

Inoue, S., Sassa, N., Kato, T., Yamauchi, Y., Hirabayashi, T., Yuguchi, Y., Maeda, M., Soeda, Y., Hattori, R., & Gotoh, M. (2020) · International Journal of Urology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 11